IMR Press / CEOG / Volume 49 / Issue 12 / DOI: 10.31083/j.ceog4912263
Open Access Original Research
Endometrial Mesenchymal Stem Cells and Their Role in the Origin and Treatment of Endometriosis
Show Less
1 Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, 610041 Chengdu, Sichuan, China
2 International Wards of Gynecology Department, Hospital of Chengdu University of Traditional Chinese Medicine, 610072 Chengdu, Sichuan, China
*Correspondence: (Ce Bian); (Guojuan Sun)
Academic Editor: Ugo Indraccolo
Clin. Exp. Obstet. Gynecol. 2022, 49(12), 263;
Submitted: 5 June 2022 | Revised: 14 August 2022 | Accepted: 16 August 2022 | Published: 30 November 2022
(This article belongs to the Special Issue Endometriosis)
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

Background: To identify endometrial mesenchymal stem cells (eMSCs) in retrograde menstruation, in various endometriosis lesions, in normal control tissues, and to investigate the association between eMSCs and endometriosis. We also plan to evaluate the effect of gonadotropin-releasing hormone agonists (GnRH-a) on eMSCs. Methods: Patients diagnosed with endometriosis were included if they had experienced surgery during the time frame 1 January 2015 to 31 December 2019 in West China Second Hospital, Sichuan University. Immunofluorescence was performed to identify eMSCs in those tissues with cell surface markers PDGFR-β/CD146. The percents of eMSCs in various tissues were calculated, and compared using analysis of variance. A two-sided pvalue less than 0.05 showed significant difference. Results: This study included 508 patients. eMSCs were identified in retrograde menstruation and numerous pathologic specimen but were not detected in normal control tissues. There was no significant difference in the percent of eMSCs between the GnRH-a treatment group and the control group (p > 0.05). Conclusions: Our study demonstrated that eMSCs played a critical role in the development and recurrence of endometriosis and that GnRH-a did not affect eMSCs. Gynecologists should regard endometriosis as a chronic disease requiring lifetime management, especially for patients with chronic pelvic pain.

endometrial mesenchymal stem cells
chronic pelvic pain
gonadotropin-releasing hormone agonists
S15059/Key Research Projects of Sichuan Province
Fig. 1.
Back to top